Cargando…
High-Flux Hemodialysis Benefits Hemodialysis Patients by Reducing Serum FGF-23 Levels and Reducing Vascular Calcification
BACKGROUND: High- and low-flux hemodialysis (HFHD and LFHD, respectively) are dialysis procedures designed to eliminate blood toxins that accumulate in end-stage renal disease. HFHD may reduce vascular calcification by removing serum fibroblast growth factor 23 (FGF-23). However, whether HFHD is bet...
Autores principales: | Fu, Xiao, Cui, Qin-Qin, Ning, Jian-Ping, Fu, Shuang-Shuang, Liao, Xiao-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648109/ https://www.ncbi.nlm.nih.gov/pubmed/26558428 http://dx.doi.org/10.12659/MSM.894894 |
Ejemplares similares
-
Phosphate control in reducing FGF23 levels in hemodialysis patients
por: Rodelo-Haad, Cristian, et al.
Publicado: (2018) -
FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients
por: Ozkok, Abdullah, et al.
Publicado: (2013) -
High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity
por: Dekker, Marijke, et al.
Publicado: (2016) -
Relationship between serum osteoprotegerin and vascular calcifications in hemodialysis patients
por: El Baz, Tarek Z., et al.
Publicado: (2017) -
Serum sTWEAK and FGF-23 Levels in Hemodialysis and Renal Transplant Patients
por: Eskandari Naji, H., et al.
Publicado: (2017)